Indication

Gastroesophageal reflux disease

Gastroesophageal reflux disease is a chronic gastrointestinal disorder characterized by the retrograde flow of gastric contents into the esophagus and upper aerodigestive tract, producing bothersome symptoms or mucosal injury. Read more about Gastroesophageal reflux disease

617 drugs 233 manufacturers

Advertisement

Drugs that treat it

Common Gastroesophageal reflux disease therapies.

Showing 595–603 of 617 drugs

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
MEDCORE, LLC

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
GLENMARK THERAP

FAMOTIDINE

PEPTIC ULCER AGENTS·MULTIPLE ENDOCRINE NEOPLASIA·+13
KESIN PHARMA
Filter & compare in the drug finder →Opens the drug finder with Gastroesophageal reflux disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gastroesophageal reflux disease.

Gastroesophageal reflux disease is a chronic gastrointestinal disorder characterized by the retrograde flow of gastric contents into the esophagus and upper aerodigestive tract, producing bothersome symptoms or mucosal injury.

It affects pediatric and adult populations globally and arises primarily from dysfunction of the antireflux barrier, such as transient lower esophageal sphincter relaxations, hypotension of the sphincter, or anatomical disruption from a hiatal hernia.

Clinically, it typically presents with heartburn and acid regurgitation, though extraesophageal manifestations such as chronic cough, laryngitis, or chest pain may also occur.

Prolonged exposure of esophageal tissue to noxious gastric acid and pepsin can lead to complications including erosive esophagitis, peptic strictures, and Barrett esophagus.

Personalize your experience

Follow Gastroesophageal reflux disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it